| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Gibson Christopher is a Director at RECURSION PHARMACEUTICALS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 20 sells.
Estimated insider holdings value: $3.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2025 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 618,175 | $5.28 | $3,263,964.00 | -38.1% | -14.7% | - | |
| Mar 27, 2025 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 138,574 | $6.04 | $836,986.96 | -11.0% | -13.6% | -50.8% | |
| Mar 6, 2025 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 40,000 | $6.48 | $259,000.00 | -1.6% | -21.3% | -44.7% | |
| Feb 6, 2025 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 40,000 | $7.90 | $316,000.00 | -1.5% | -42.1% | -45.0% | |
| Jan 10, 2025 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 40,000 | $7.18 | $287,200.00 | -2.6% | -34.4% | -32.3% | |
| Dec 5, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 40,000 | $7.14 | $285,600.00 | -2.6% | -0.2% | -28.5% | |
| Nov 14, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 40,000 | $7.55 | $301,800.00 | -2.6% | +20.7% | -40.1% | |
| Oct 3, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 40,000 | $6.12 | $244,800.00 | -2.6% | +19.0% | -9.4% | |
| Sep 5, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 40,000 | $6.09 | $243,600.00 | -2.6% | +15.6% | -25.3% | |
| Aug 8, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 50,000 | $6.86 | $343,000.00 | -3.2% | +5.0% | -19.3% |